Treatment adherence and quality of sleep in schizophrenia outpatients

International Journal of Psychiatry in Clinical Practice

Volumn 18, Issue 1, 2014, Pages 70-76

  Afonso, Pedro ^a   Brissos, Sofia ^a,b   Cañas, Fernando ^c   Bobes, Julio ^d   Bernardo Fernandez, Ivan ^e  

^a Lisbon s Psychiatric Hospitalar Centre   (Portugal)

^b Janssen Pharmaceutical   (Portugal)

^c UNIVERSITY OF OVIEDO   (Spain)

^d Hospital Dr Rodríguez Lafora   (Spain)

^e Janssen   (Spain)

Author keywords

Compliance; Positive and negative symptoms; Schizophrenia; Sleep quality; Treatment adherence

Indexed keywords

ADULT; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; OUTPATIENTS; RECURRENCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SLEEP; SLEEP DISORDERS; SOCIAL SUPPORT;

EID: 84894059850     PISSN: 13651501     EISSN: 14711788     Source Type: Journal    
DOI: 10.3109/13651501.2013.845219     Document Type: Article

References (41)

1. Afonso P, Brissos S, Figueira ML, Paiva T. Schizophrenia patients with predominantly positive symptoms have more disturbed sleep-wake cycles measured by actigraphy. Psychiatry Res 2011; 189: 62-66
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC, 4Thed. (DSM IV-TR); 2000
3. Benson KL. Sleep in schizophrenia. Sleep Med Clin 2008; 3: 251-260
4. Bromundt V, K öster M, Georgiev-Kill A, Opwis K, Wirz-Justice A, Stoppe G, Cajochen C. Sleep-wake cycles and cognitive functioning in schizophrenia. Br JPsychiatry 2011; 198: 269-276
5. Buisse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213
6. Chemerinski E, Ho B, Flaum M, Arndt S, Fleming F, Andreasen NC. Insomnia as a predictor for symptom worsening following antipsychotic withdrawal in schizophrenia. Compr Psychiatry 2002; 43: 393-396
7. Cohrs S, Meier A, Neumann AC, Jordan W, R ü ther E, Rodenbeck A. Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: A randomized, controlled, crossover trial of 12 healthy male subjects. J Clin Psychiatry 2005; 66: 989-996
8. Cohrs S, Rodenbeck A, Guan Z, Pohlmann K, Jordan W, Meier A, R üther E. Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology 2004; 174: 421-429
9. Cohrs S. Sleep disturbances in patients with schizophrenia: Impact and Effect of antipsychotics. CNS Drugs 2008; 22: 939-962
10. DeMartinis NA, Winokur A. Effects of psychiatric medications on sleep and sleep disorders. CNS Neurol Disord Drug Targets 2007; 6: 17-29
11. Dencker SJ, Malm U, Lepp M. Schizophrenic relapse aft er drug withdrawal is predictable. Acta Psychiatr Scand 1986; 73: 181-185
12. Emsley R, Oosthuizen PP, Koen L, Niehaus DJ, Martinez G. Symptom recurrence following intermittent treatment in fi rst-episode schizophrenia successfully treated for 2 years: A 3-year open-label clinical study. J Clin Psychiatry 2012; 73: E541-e547
13. Glick ID, Stekoll AH, Hays S. The role of the family and improvement in treatment maintenance, adherence, and outcome for schizophrenia. J Clin Psychopharmacol 2011; 31: 82-85
14. Hinze-Selch D, Mullington J, Orth A, Lauer CJ, Pollm ä cher T. Effects of clozapine on sleep: A longitudinal study. Biol Psychiatry 1997; 42: 260-266
15. Hofstetter JR, Lysaker PH, Mayeda AR. Quality of sleep in patients with schizophrenia is associated with quality of life and coping. BMC Psychiatry 2005; 5: 13
16. Kane JM. Utilization of long-acting antipsychotic medication in patient care. CNS Spectr 2006; 11: 1-7
17. Kang SG, Lee HJ, Jung SW, Cho SN, Han C, Kim YK, et al. Characteristics and clinical correlates of restless legs syndrome in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1078-1083
18. Kato M, Kajimura N, Okuma T, Sekimoto M, Watanabe T, Yamadera H, Takahashi K. Association between delta waves during sleep and negative symptoms in schizophrenia. Pharmaco-eeg studies by using structurally diff erent hypnotics. Neuropsychobiology 1999; 39: 165-172
19. Keshavan MS, Reynolds CF III, Miewald MJ, Montrose DM, Sweeney JA, Vasko RC Jr, Kupfer DJ. Delta sleep defi cits in schizophrenia: Evidence from automated analyses of sleep data. Arch Gen Psychiatry 1998; 55: 443-448
20. Lee JH, Woo JI, Meltzer HY. Effects of clozapine on sleep measures and sleep-associated changes in growth hormone and cortisol in patients with schizophrenia. Psychiatry Res 2001; 103: 157-166
21. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al.; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209-1223
22. Luthringer R, Staner L, Noel N, Muzet M, Gassmann-Mayer C, Talluri K, et al. A double-blind, placebo-controlled, randomized study evaluating the Effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia. Int Clin Psychopharmacol 2007; 22: 299-308
23. Masand PS, Narasimhan M. Improving adherence to antipsychotic pharmacotherapy. Curr Clin Pharmacol 2006; 1: 47-56
24. Masand PS, Roca M, Turner MS, Kane JM. Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: A review. Prim Care Companion J Clin Psychiatry 2009; 11: 147-154
25. Monti JM, Monti D. Sleep in schizophrenia patients and the Effects of antipsychotic drugs. Sleep Med Rev 2004; 8: 133-148
26. Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL. Psychological and behavioral treatment of insomnia:update of the recent evidence (1998-2004). Sleep 2006; 29: 1398-1414
27. Müller MJ, Rossbach W, Mann K, R ö schke J, M ü ller-Siecheneder F, Bl ümler M, et al. Sub chronic Effects of olanzapine on sleep EEG in schizophrenic patients with predominantly negative symptoms. Pharmacopsychiatry 2004; 37: 157-162
28. National Collaborating Centre for Mental Health commissioned by the National Institute for Health & Clinical Excellence. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care. National Clinical Guideline Number 82. The British Psychological Society & The Royal College of Psychiatrists, 2010
29. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale (BPRS): Recent developments in ascertainment and scaling. Psychopharmacol Bull 1988; 24: 97-99
30. Palmese LB, DeGeorge PC, Ratliff JC, Srihari VH, Wexler BE, Krystal AD, Tek C. Insomnia is frequent in schizophrenia and associated with night eating and obesity. Schizophr Res 2011; 133: 238-243
31. Poulin J, Daoust AM, Forest G, Stip E, Godbout R. Sleep architecture and its clinical correlates in fi rst episoDe and neurolepticnaive patients with schizophrenia. Schizophr Res 2003; 62: 147-153
32. Ritsner M, Kurs R, Ponizovsky A, Hadjez J. Perceived quality of life in schizophrenia: Relationships to sleep quality. Qual Life Res 2004; 13: 783-791
33. Robinson D, Woerner MG, Alvir JM, Geisler S, Koreen A, Sheitman B, et al. Predictors of relapse following response from a fi rst episode of schizophrenia or schizoaff ective disorder. Arch Gen Psychiatry 1999; 56: 241-247
34. Salin-Pascual RJ, Herrera-Estrella M, Galicia-Polo L, Laurrabaquio MR. Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep effi ciency. Biol Psychiatry 1999; 46: 141-143
35. San L, Ciudad A, Alvarez E, Gilaberte I. Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: Prevalence and associations in a cross-sectional study. Eur Psychiatry 2007; 22: 490-498
36. Tandon R, Shipley JE, Taylor S, Greden JF, Eiser A, DeQuardo J, Goodson J. Electroencephalographic sleep abnormalities in schizophrenia: Relationship to positive/negative symptoms and prior neuroleptic treatment. Arch Gen Psychiatry 1992; 49: 185-194
37. Walther S, Koschorke P, Horn H, Strik W. Objectively measured motor activity in schizophrenia challenges the validity of expert ratings. Psychiatry Res 2009; 169: 187-190
38. Weiden PJ, Kozma C, Grogg A, Locklear J. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv 2004; 55: 886-891
39. Wirz-Justice A, Haug HJ, Cajochen C. Disturbed circadian restactivity cycles in schizophrenic patients: An Effect of drugs? Schizophrenia Bul 2001; 27: 497-502
40. Wulff K, Dijk DJ, Middleton B, Foster RG, Joyce EM. Sleep and circadian rhythm disruption in schizophrenia. Br J Psychiatry 2012; 200: 308-316
41. Yamashita H, Morinobu S, Yamawaki S, Horiguchi J, Nagao M. Effect of risperidone on sleep in schizophrenia: A comparison with haloperidol. Psychiatry Res 2002; 109: 137-142